<doc>
  <docmeta id="113hr2285ih">
    <bill congress="113" type="hr" number="2285" version="ih"/>
    <revision size="41186" annotations="0" status="complete" id="6" commit-time="2014-01-17T18:53:44Z" committer="mbohmer" doc="113hr2285ih/6.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H5255DEF9D94A4CBCB79A81DEB396C684" public-private="public">
	<metadata>
<dublinCore>
<dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">113 HR 2285 IH: Strategies to Address Antimicrobial Resistance Act</dc:title>
<dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">U.S. House of Representatives</dc:publisher>
<dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-06-06</dc:date>
<dc:format xmlns:dc="http://purl.org/dc/elements/1.1/">text/xml</dc:format>
<dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">EN</dc:language>
<dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>H. R. 2285</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20130606">June 6, 2013</action-date>
			<action-desc>
        <sponsor name-id="M001142">Mr. Matheson</sponsor>
			 introduced the following bill; which was referred to the
			 <committee-name committee-id="HIF00">Committee on Energy and
			 Commerce</committee-name>
      </action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To amend the Public Health Service Act to enhance efforts
		  to address antimicrobial resistance, and for other purposes.</official-title>
	</form>
	<legis-body id="H54F647D5B719483890D5A46DEA932A4B" style="OLC">
		<section id="H517BC4B2EDBA4F1588936DD35C12E4C3" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
      <text display-inline="no-display-inline">This Act may be cited as the
			 <quote>
          <short-title>Strategies to Address Antimicrobial
			 Resistance Act</short-title>
        </quote>.</text>
		</section>
    <section id="HF16DD609B9D94799AD333696713019DF">
      <enum>2.</enum>
      <header>Findings</header>
      <text display-inline="no-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref> finds as follows:</text>
			<paragraph id="HB78566AF791C46A7B02D02772F004D73">
        <enum>(1)</enum>
        <text>The advent of the
			 antibiotic era has saved millions of lives and allowed for incredible medical
			 progress; however, the increased use and overuse of antimicrobial drugs have
			 correlated with increased rates of antimicrobial resistance.</text>
			</paragraph>
      <paragraph id="H78AC89EBFAC0492D801DA744C8DFBEE9">
        <enum>(2)</enum>
        <text>Through mutation
			 as well as other mechanisms, bacteria and other infectious disease-causing
			 organisms—viruses, fungi, and parasites—develop resistance to antimicrobial
			 drugs over time. The more antimicrobial drugs are used, whether appropriately
			 or inappropriately, the more this contributes to the development of
			 antimicrobial resistance.</text>
			</paragraph>
      <paragraph id="HF01C4595AD7A4852B90DCAA94EC93345">
        <enum>(3)</enum>
        <text>Scientific
			 evidence suggests that the development of antimicrobial resistance in humans is
			 not due only to use of antimicrobial drugs in humans, but also may be caused by
			 the use of antimicrobial drugs in food-producing animals.</text>
			</paragraph>
      <paragraph id="H2C1EEB3DAEA94171BCE7AC977A7D5F10">
        <enum>(4)</enum>
        <text>A
			 study estimates that in 2005 more than 94,000 invasive methicillin-resistant
			 Staphylococcus aureus (MRSA) bacterial infections occurred in the United States
			 and more than 18,500 of these infections resulted in death—7 times more than a
			 decade earlier.</text>
			</paragraph>
      <paragraph id="H34D7D62E98A545F69DC71393AA853432">
        <enum>(5)</enum>
        <text>The 2009 Influenza
			 A: H1N1 virus outbreak, and the yearly seasonal influenza outbreaks, exacerbate
			 concerns about antiviral resistance given that so few antivirals are available
			 to treat influenza as well as secondary bacterial infections due to MRSA,
			 antibiotic-resistant Streptococcus pneumonia, and other bacteria that cause
			 respiratory diseases. Given that, during the 1918 influenza pandemic, many
			 thousands of deaths were caused by complications due to secondary bacterial
			 infections and not by the influenza virus itself.</text>
			</paragraph>
      <paragraph id="HA98D3263F54447449DDD476B2F15CB20">
        <enum>(6)</enum>
        <text>Each year, nearly
			 2,000,000 people contract bacterial infections in hospitals and approximately
			 90,000 of these people die from these infections. Many of these infections are
			 resistant to one or more commonly used antibiotics.</text>
			</paragraph>
      <paragraph id="H63A85114B96540B6BB2D3969ADFE41C2">
        <enum>(7)</enum>
        <text>A
			 2012 study conducted at Columbia University (<term>Clinical Infectious
			 Disease</term>, September 2012) found that each antibiotic-resistant infection
			 cost, on average, over $15,000 more to treat than susceptible
			 infections.</text>
			</paragraph>
      <paragraph id="H56A75B2442414E87A522E51697C5175B">
        <enum>(8)</enum>
        <text>The costs of
			 antimicrobial-resistant infections in terms of lives lost and the economy will
			 only rise as antimicrobial resistance continues to spread.</text>
			</paragraph>
    </section>
    <section id="HEFAF86356A8C47D09EE271481DE91DF9">
      <enum>3.</enum>
      <header>Antimicrobial
			 resistance task force</header>
      <text display-inline="no-display-inline">
        <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
          <cato:entity-ref entity-type="act" value="Public Health Service Act/s:319E">Section
			 319E of the Public Health Service Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/247d-5">
            <cato:entity-ref entity-type="uscode" value="usc/42/247d–5">42 U.S.C. 247d–5</cato:entity-ref>
          </external-xref>)</cato:entity> is amended—</text>
			<paragraph id="HBFBA07BFDBDD472AA2496AB69D516268">
        <enum>(1)</enum>
        <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319E/ss:a">subsection
			 (a)</cato:entity-ref>—</text>
				<subparagraph id="H68DA0F305A7B43B6AE032442234A3D5E">
          <enum>(A)</enum>
          <text>in the subsection
			 heading, by striking <quote>
              <header-in-text level="subsection" style="OLC">Task
			 Force</header-in-text>
            </quote> and inserting the following:
			 <quote>
              <header-in-text level="subsection" style="OLC">
                <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="National Institute of Allergy and Infectious Diseases" entity-parent-id="7500" proposed="true">Antimicrobial Resistance
			 Office, Task Force</cato:entity-ref>, and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Public Health Antimicrobial Advisory Board" entity-parent-id="7500" proposed="true">Advisory Board</cato:entity-ref>
              </header-in-text>
            </quote>;</text>
				</subparagraph>
        <subparagraph id="HFD3C55BEF8E34795B66D690D7ECAD9D6">
          <enum>(B)</enum>
          <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319E/ss:a/p:1">paragraph
			 (1)</cato:entity-ref>—</text>
					<clause id="H292353FDB6534B6498403DAA6145A2AE">
            <enum>(i)</enum>
            <text>by
			 striking <quote>as of the date of the enactment of this section</quote> and
			 inserting <quote>as of September 30, 2006</quote>; and</text>
					</clause>
          <clause id="H72406EFF398343DFB5EC083908DF9D38">
            <enum>(ii)</enum>
            <text>by
			 adding at the end the following: <quote>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall, not later than 1
			 year after the date of enactment of the Strategies to Address Antimicrobial
			 Resistance Act, direct the Assistant Secretary of Health to establish an
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Antimicrobial Resistance Office" entity-parent-id="7500" proposed="true">Antimicrobial Resistance Office</cato:entity-ref> and appoint a director to that Office. The
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall, not later than 1 year after the date of enactment of such Act,
			 establish the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Public Health Antimicrobial Advisory Board" entity-parent-id="7500" proposed="true">Public Health Antimicrobial Advisory Board</cato:entity-ref> as an advisory board
			 to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Antimicrobial Resistance Office" entity-parent-id="7500" proposed="true">Director of the Antimicrobial Resistance Office</cato:entity-ref>. The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Antimicrobial Resistance Office" entity-parent-id="7500" proposed="true">Director of the
			 Antimicrobial Resistance Office</cato:entity-ref> shall serve as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Antimicrobial Resistance Task Force" entity-parent-id="7500" proposed="true">Director of the
			 Antimicrobial Resistance Task Force</cato:entity-ref>. To avoid duplication and ensure that
			 Federal resources are used efficiently and effectively, the Director shall work
			 in conjunction with the Federal agencies represented on the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Antimicrobial Resistance Task Force" entity-parent-id="7500" proposed="true">Task Force</cato:entity-ref> to
			 coordinate all antimicrobial resistance activities undertaken and supported by
			 the Federal Government, including the activities and budgetary allocations of
			 the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Antimicrobial Resistance Office" entity-parent-id="7500" proposed="true">Office</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Antimicrobial Resistance Task Force" entity-parent-id="7500" proposed="true">Task Force</cato:entity-ref>, and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Public Health Antimicrobial Advisory Board" entity-parent-id="7500" proposed="true">Public Health Antimicrobial Advisory
			 Board</cato:entity-ref>.</quote>;</text>
					</clause>
        </subparagraph>
        <subparagraph id="H21936F2C917C48B7992B76479FD2303C">
          <enum>(C)</enum>
          <text>by amending
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319E/ss:a/p:2">paragraph (2)</cato:entity-ref> to read as follows:</text>
					<quoted-block id="HB7A6D0EF49B24235AD44FEC46F1F88E0" style="OLC">
						<paragraph id="H6AC59EF3ABD0442EB9B002174A4D288E">
              <enum>(2)</enum>
              <header>Members</header>
							<subparagraph id="H33AFEAEE0D74485C961F3ECF8E368133">
                <enum>(A)</enum>
                <header>Members of the
				antimicrobial resistance task force</header>
                <text>The task force described in
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319E/ss:a/p:1">paragraph (1)</cato:entity-ref> shall be composed of representatives of such Federal agencies as
				the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> determines necessary, including representation of the
				following:</text>
								<clause id="H4EA00CB378354A0496523A867FA9FACB">
                  <enum>(i)</enum>
                  <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Antimicrobial Resistance Office" entity-parent-id="7500" proposed="true">Antimicrobial
				Resistance Office</cato:entity-ref>.</text>
								</clause>
                <clause id="H17DFDD2491D14141B76D0FFFC885F180">
                  <enum>(ii)</enum>
                  <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Office of the Assistant Secretary for Preparedness and Response" entity-parent-id="7500">Assistant
				Secretary for Preparedness and Response</cato:entity-ref>.</text>
								</clause>
                <clause id="H89B26B139338495484A1EF3B572EF59F">
                  <enum>(iii)</enum>
                  <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Biomedical Advanced Research and Development Authority" entity-parent-id="7500">Biomedical
				Advanced Research and Development Authority</cato:entity-ref>.</text>
								</clause>
                <clause id="H1914E54425BB4D68B60912AFCCF64004">
                  <enum>(iv)</enum>
                  <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7523">Centers for
				Disease Control and Prevention</cato:entity-ref>.</text>
								</clause>
                <clause id="HC560AAF9B1624E439EEFC25C28CC2E15">
                  <enum>(v)</enum>
                  <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug
				Administration</cato:entity-ref>.</text>
								</clause>
                <clause id="H977E2353522A4EA292C59BA7D9C0F58C">
                  <enum>(vi)</enum>
                  <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7529">National
				Institutes of Health</cato:entity-ref>.</text>
								</clause>
                <clause id="H8CCCF822FF634E7A9629914D6476C223">
                  <enum>(vii)</enum>
                  <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7528">Agency for
				Healthcare Research and Quality</cato:entity-ref>.</text>
								</clause>
                <clause id="HC04016406E3E45A188D1FE870F290299">
                  <enum>(viii)</enum>
                  <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7530">Centers for
				Medicare &amp; Medicaid Services</cato:entity-ref>.</text>
								</clause>
                <clause id="HE5FE332A0415420D9233A44B11A5EE16">
                  <enum>(ix)</enum>
                  <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7526">Health
				Resources and Services Administration</cato:entity-ref>.</text>
								</clause>
                <clause id="H13BCC322FECF436B8BF79EB6D2EAA713">
                  <enum>(x)</enum>
                  <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1200">Department of
				Agriculture</cato:entity-ref>.</text>
								</clause>
                <clause id="HC92EFC7797654C55BD98A5AC81AB1193">
                  <enum>(xi)</enum>
                  <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="9100">Department of
				Education</cato:entity-ref>.</text>
								</clause>
                <clause id="HE8AE912E5A064E52BF3816DCE2030DD8">
                  <enum>(xii)</enum>
                  <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="9700">Department
				of Defense</cato:entity-ref>.</text>
								</clause>
                <clause id="HA750257366BB4B358AD5137FD7C415A8">
                  <enum>(xiii)</enum>
                  <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="3600">Department
				of Veterans Affairs</cato:entity-ref>.</text>
								</clause>
                <clause id="H5DABD0B8E9494F208D6A42D15ADA4F52">
                  <enum>(xiv)</enum>
                  <text>The
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="6800">Environmental Protection Agency</cato:entity-ref>.</text>
								</clause>
                <clause id="HCD457B59FFC046C59928F835DFDF702B">
                  <enum>(xv)</enum>
                  <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7000">Department of
				Homeland Security</cato:entity-ref>.</text>
								</clause>
                <clause id="HC193AAB425444864B5DFD53740468984">
                  <enum>(xvi)</enum>
                  <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7200">United States Agency for International
			 Development</cato:entity-ref>.</text>
								</clause>
              </subparagraph>
              <subparagraph id="H173F1052025D4E13BFAE2C0D0C436864">
                <enum>(B)</enum>
                <header>Members of the
				public health antimicrobial advisory board</header>
								<clause id="H8F65C7AFFAD6444ABC28E80768DCA38F">
                  <enum>(i)</enum>
                  <header>In
				general</header>
                  <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Public Health Antimicrobial Advisory Board" entity-parent-id="7500" proposed="true">Public Health Antimicrobial Advisory Board</cato:entity-ref> shall be
				composed of 19 voting members, appointed by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>. Such members shall
				include experts from the medical professions (including hospital and
				community-based physicians), pharmacy, public health, veterinary, research, and
				international health communities, as well as one representative from a public
				interest group.</text>
								</clause>
                <clause id="H2FFD721770A94DEB81F4721EC341FF17">
                  <enum>(ii)</enum>
                  <header>Terms</header>
                  <text>Each
				member appointed under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319E/ss:a/p:2/sp:B/cl:i" proposed="true">clause (i)</cato:entity-ref> shall be appointed for a term of 3 years,
				except that of the 19 members first appointed—</text>
									<subclause id="HC69A4A3AD71748B2987C41ABA1F9C11B">
                    <enum>(I)</enum>
                    <text>6 shall be
				appointed for a term of 12 months; and</text>
									</subclause>
                  <subclause id="HBD31204C21684856AE69ACFE5573A44E">
                    <enum>(II)</enum>
                    <text>6 shall be
				appointed for a term of 2 years.</text>
									</subclause>
                </clause>
                <clause id="H74BC098BCB584A4A9E3EA98939BFD109">
                  <enum>(iii)</enum>
                  <header>Chair</header>
                  <text>The
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall appoint a <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Public Health Antimicrobial Advisory Board" entity-parent-id="7500" proposed="true">Chair of the Public Health Antimicrobial Advisory
				Board</cato:entity-ref> from among its members to lead and supervise the activities of the
				Advisory Board.</text>
								</clause>
                <clause id="HBF61609EAE5B4AC5A1F272F5F58D5E92">
                  <enum>(iv)</enum>
                  <header>Disclosure of
				financial interests</header>
                  <text>Prior to a meeting of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Public Health Antimicrobial Advisory Board" entity-parent-id="7500" proposed="true">Public Health
				Antimicrobial Advisory Board</cato:entity-ref>, each member of the Advisory Board shall disclose
				to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> any potential, relevant financial interests as defined under
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="uscode" value="usc/18/208/a">
                      <external-xref legal-doc="usc" parsable-cite="usc/18/208">section 208(a)</external-xref> of title 18, United States
				Code</cato:entity-ref>.</text>
								</clause>
              </subparagraph>
            </paragraph>
            <after-quoted-block>;</after-quoted-block>
          </quoted-block>
				</subparagraph>
        <subparagraph id="H99B2FE043EB7478689061DCCC7EB06FB">
          <enum>(D)</enum>
          <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319E/ss:a/p:3/sp:B">paragraph
			 (3)(B)</cato:entity-ref>, by striking <quote>in consultation with the task force described in
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319E/ss:a/p:1">paragraph (1)</cato:entity-ref> and</quote> and inserting <quote>acting through the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Antimicrobial Resistance Office" entity-parent-id="7500" proposed="true">Director of
			 the Antimicrobial Resistance Office</cato:entity-ref> and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7523">Director of the Centers for Disease
			 Control and Prevention</cato:entity-ref>, and in consultation with</quote>; and</text>
				</subparagraph>
        <subparagraph id="HED448A5DD756461BA1690AF2BDCEF438">
          <enum>(E)</enum>
          <text>by amending
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319E/ss:a/p:4">paragraph (4)</cato:entity-ref> to read as follows:</text>
					<quoted-block id="HC1D16AA105DC49F9ACFF1CAE1562D157" style="OLC">
						<paragraph id="HC859C07D5E8F42F1B0083F7527C847E3">
              <enum>(4)</enum>
              <header>Meetings and
				duties</header>
							<subparagraph id="HD5BB2013B9B0437DA4CF0ACC28C01A37">
                <enum>(A)</enum>
                <header>Antimicrobial
				resistance office duties</header>
                <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Antimicrobial Resistance Office" entity-parent-id="7500" proposed="true">Director of the Antimicrobial
				Resistance Office</cato:entity-ref>, working in conjunction with the Federal agencies that are
				represented on the task force described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319E/ss:a/p:1">paragraph (1)</cato:entity-ref>, shall issue an update
				to the Public Health Action Plan to Combat Antimicrobial Resistance within 1
				year of the establishment of the Office and annually thereafter. The updates
				shall include enhanced plans for addressing antimicrobial resistance in the
				United States and internationally. The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Antimicrobial Resistance Office" entity-parent-id="7500" proposed="true">Director of the Office</cato:entity-ref> shall post on a
				website these updates as well as summaries of all non-proprietary data the Task
				Force makes available. The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Antimicrobial Resistance Office" entity-parent-id="7500" proposed="true">Director of the Antimicrobial Resistance Office</cato:entity-ref>
				shall work in conjunction with the Federal agencies that are represented on the
				task force described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319E/ss:a/p:1">paragraph (1)</cato:entity-ref>, and in consultation with the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Public Health Antimicrobial Advisory Board" entity-parent-id="7500" proposed="true">Public
				Health Antimicrobial Advisory Board</cato:entity-ref>, to—</text>
								<clause id="HFE09D4A68B6740C0A5C0BC9B37C7BDA3">
                  <enum>(i)</enum>
                  <text>establish
				benchmarks for achieving the goals set forth in the action plan;</text>
								</clause>
                <clause id="H76577B4A7577415A8A239BB580999C60">
                  <enum>(ii)</enum>
                  <text>assess the
				ongoing, observed patterns of emergence of antimicrobial resistance, and their
				impact on clinical outcomes in terms of how patients feel, function, or
				survive;</text>
								</clause>
                <clause id="H8700417C3A314585A0D875A807D77ADE">
                  <enum>(iii)</enum>
                  <text>assess how
				antimicrobial products are being used in humans, animals, plants, and the
				environment and the risks and benefits of those uses in furthering the
				development of resistance and the implications thereof for patient safety and
				public health;</text>
								</clause>
                <clause id="H35A8C53AFCA7462A9AD233E745E862F0">
                  <enum>(iv)</enum>
                  <text>establish a
				priority list of human infectious diseases with the greatest need for
				development of new point-of-care and other diagnostics, antimicrobial drugs,
				and vaccines, and in particular serious and life-threatening resistant
				infections, for which there are few or no diagnostic, treatment, or prevention
				options;</text>
								</clause>
                <clause id="H603B5212B5AD4AC8ACCE7BD20FCC2ABC">
                  <enum>(v)</enum>
                  <text>recommend basic,
				clinical, epidemiological, prevention, and translational research where
				additional federally supported studies may be beneficial;</text>
								</clause>
                <clause id="H2B58BB759515467D80EC8CEC396C6DB1">
                  <enum>(vi)</enum>
                  <text>recommend how to
				support antimicrobial development through Food and Drug Administration
				activities, including through the agency’s Critical Path Initiative and the
				Reagan-Udall Foundation;</text>
								</clause>
                <clause id="H8DCE4490DD054F0590EF643028E05A9D">
                  <enum>(vii)</enum>
                  <text>recommend how
				best to strengthen and link antimicrobial resistance-related surveillance and
				prevention and control activities; and</text>
								</clause>
                <clause id="H503EBCD00CE349128B94ABAFFB3C90DA">
                  <enum>(viii)</enum>
                  <text>collaborate
				with the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Office of the Assistant Secretary for Preparedness and Response" entity-parent-id="7500">Assistant Secretary for Preparedness and Response</cato:entity-ref> to ensure that
				strategies to address antimicrobial-resistance are coordinated with initiatives
				aimed at pandemic influenza, severe acute respiratory syndrome, and
				bioterrorism.</text>
								</clause>
              </subparagraph>
              <subparagraph id="HF61C766DF3A94D09AE23BC5CE40585C4">
                <enum>(B)</enum>
                <header>Antimicrobial
				resistance task force meetings and duties</header>
								<clause id="H0A9875B94A9745B7B4F6C79E96DE9139">
                  <enum>(i)</enum>
                  <header>Meetings</header>
                  <text>The
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Antimicrobial Resistance Task Force" entity-parent-id="7500" proposed="true">Antimicrobial Resistance Task Force</cato:entity-ref> shall convene periodically as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Antimicrobial Resistance Task Force" entity-parent-id="7500" proposed="true">Director
				of the Antimicrobial Resistance Task Force</cato:entity-ref> determines to be appropriate, but
				not fewer than twice a year, to consider issues relating to antimicrobial
				resistance.</text>
								</clause>
                <clause id="H05EB27D66A2C435D994D2FD7BF2A852E">
                  <enum>(ii)</enum>
                  <header>Public health
				action plan</header>
                  <text>At least twice a year, the task force described in
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319E/ss:a/p:1">paragraph (1)</cato:entity-ref> shall have a meeting to review, discuss, and further develop the
				Public Health Action Plan to Combat Antimicrobial Resistance first issued by
				the interagency task force on antimicrobial resistance in 2001. Among other
				issues, the task force may discuss and review, based on current need or
				concern—</text>
									<subclause id="H96A6EEBA35D4411BB95D888E71B3C74F">
                    <enum>(I)</enum>
                    <text>antimicrobial
				clinical susceptibility concentrations proposed, established, or updated by the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref>;</text>
									</subclause>
                  <subclause id="H04C619EEAC1C47A79EAB86FD9BBEB06C">
                    <enum>(II)</enum>
                    <text>data obtained by
				government agencies and, as possible, by private sources on emerging
				antimicrobial resistance related to clinical outcomes as well as data related
				to how antimicrobial drugs may have been used inappropriately;</text>
									</subclause>
                  <subclause id="H6D63D36BD5934DC5BFA2B402006AFCD9">
                    <enum>(III)</enum>
                    <text>surveillance
				data and prevention and control activities regarding emerging antimicrobial
				resistance from reliable sources including the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7523">Centers for Disease Control and
				Prevention</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="9700">Department of Defense</cato:entity-ref>, the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="3600">Department of Veterans Affairs</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1200">Department of Agriculture</cato:entity-ref>, the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="6800">Environmental Protection Agency</cato:entity-ref>, and as feasible from private sources and
				international bodies;</text>
									</subclause>
                  <subclause id="HE6250CC0E6BD441395965245D069E688">
                    <enum>(IV)</enum>
                    <text>data on the
				amount of antimicrobial products used in humans, animals, plants, and the
				environment from reliable sources, including data from the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7523">Centers for Disease
				Control and Prevention</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="6800">Environmental
				Protection Agency</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="3600">Department of Veterans Affairs</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7530">Centers for Medicare
				&amp; Medicaid Services</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7000">Department of Homeland Security</cato:entity-ref>, and the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1200">Department of Agriculture</cato:entity-ref>, and as feasible from private sources and
				international bodies;</text>
									</subclause>
                  <subclause id="H4E5375E28CA14A79A609791D1D57F921">
                    <enum>(V)</enum>
                    <text>the impact of
				antimicrobial resistance on human health resulting from the approval of
				antimicrobial drugs for use in humans, animals, or plants (including
				consideration of and recommendations on potential management plans to limit and
				reduce the negative impacts of such resistance on human health and
				consideration of the benefits to animal health and food safety);</text>
									</subclause>
                  <subclause id="H8FD06A3AC4A042A29A5CB362F9093321">
                    <enum>(VI)</enum>
                    <text display-inline="yes-display-inline">reports of federally supported
				antimicrobial resistance research and antimicrobial drug, related diagnostics,
				and vaccine development for antimicrobial resistant infections (such as
				methicillin-resistant Staphylococcus aureus (MRSA)) and other research
				activities (including clinical, epidemiological, prevention, and
				trans­la­tion­al research) obtained from Federal agencies, as well as reports
				of research sponsored by other countries, industry, and non-governmental
				organizations;</text>
									</subclause>
                  <subclause id="H56601F3E183640908926658E2DB31C7D">
                    <enum>(VII)</enum>
                    <text>reports on
				efforts by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref> to develop policies and guidance
				which encourage antimicrobial drug, related diagnostics, and vaccine
				development and appropriate use while maintaining high standards for safety and
				effectiveness;</text>
									</subclause>
                  <subclause id="H053BE230190A4D88A90952DF588E56AC">
                    <enum>(VIII)</enum>
                    <text>quality
				measures, which may include health plan employer data and information set
				(HEDIS) measures, pertaining to appropriate use of antimicrobial drugs;
				and</text>
									</subclause>
                  <subclause id="H62C8A5D7349A4BB8B038956B4701794F">
                    <enum>(IX)</enum>
                    <text>other data and
				issues the task force described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319E/ss:a/p:1">paragraph (1)</cato:entity-ref> identifies as relevant to the
				issue of antimicrobial resistance.</text>
									</subclause>
                </clause>
                <clause id="HB1FFC6D8FBC646999C6E6A7745AD661B">
                  <enum>(iii)</enum>
                  <header>Pending
				applications</header>
                  <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref> may consult with
				the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Antimicrobial Resistance Office" entity-parent-id="7500" proposed="true">Director of the Antimicrobial Resistance Office</cato:entity-ref> concerning the pending
				application of any antimicrobial drug application submitted to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>
				under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505">section 505</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:512">512 of the Federal Food, Drug, and Cosmetic Act</cato:entity-ref> or the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act">Public Health Service Act</cato:entity-ref>.</text>
								</clause>
              </subparagraph>
              <subparagraph id="H21CA9BFB86ED481887B78F9AAEAD1780">
                <enum>(C)</enum>
                <header>Public health
				antimicrobial advisory board meetings and duties</header>
								<clause id="H237325FB7B764019BEF8DE884615597E">
                  <enum>(i)</enum>
                  <header>Meetings</header>
                  <text>The
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Public Health Antimicrobial Advisory Board" entity-parent-id="7500" proposed="true">Public Health Antimicrobial Advisory Board</cato:entity-ref> shall meet as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Public Health Antimicrobial Advisory Board" entity-parent-id="7500" proposed="true">Chair of the
				Public Health Antimicrobial Advisory Board</cato:entity-ref> determines to be appropriate,
				preferably in conjunction with meetings of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Antimicrobial Resistance Task Force" entity-parent-id="7500" proposed="true">Antimicrobial Resistance Task
				Force</cato:entity-ref>, but not fewer than 2 times each year.</text>
								</clause>
                <clause id="H245F4215F6C44425A2FA760BB6146B59">
                  <enum>(ii)</enum>
                  <header>Recommendations</header>
                  <text>The
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Public Health Antimicrobial Advisory Board" entity-parent-id="7500" proposed="true">Public Health Antimicrobial Advisory Board</cato:entity-ref> shall make recommendations to the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Antimicrobial Resistance Office" entity-parent-id="7500" proposed="true">Antimicrobial Resistance Office</cato:entity-ref>, regarding—</text>
									<subclause id="H247298D56FCF48CB91016F3E1ABCFF06">
                    <enum>(I)</enum>
                    <text>ways to encourage
				the availability of an adequate supply of safe and effective antimicrobial
				products, related diagnostics, and vaccines;</text>
									</subclause>
                  <subclause id="H71040AD137544842ADC725752898D7FF">
                    <enum>(II)</enum>
                    <text>research
				priorities and other measures (such as antimicrobial drug resistance management
				plans) to enhance the safety and efficacy of antimicrobial products;</text>
									</subclause>
                  <subclause id="HAA0985B30E73446A9F011839B97E9CD9">
                    <enum>(III)</enum>
                    <text>how best to
				implement and update the goals of the Public Health Action Plan to Combat
				Antimicrobial Resistance;</text>
									</subclause>
                  <subclause id="H1110605785774561B94D765BAC19A2F2">
                    <enum>(IV)</enum>
                    <text>incentives
				necessary to establish uniform mechanisms (which could include electronic
				surveillance systems) and data sets for State and local reporting of
				resistance;</text>
									</subclause>
                  <subclause id="HC5B62BF2C89A4EF3933CD1C9E75F02D5">
                    <enum>(V)</enum>
                    <text>the adequacy of
				existing United States antimicrobial resistance and use surveillance;</text>
									</subclause>
                  <subclause id="H9EE13FB9F89F48F59E31666A9DE05568">
                    <enum>(VI)</enum>
                    <text>the development
				of a national plan for the collection and analysis of isolates of resistant
				pathogens, including establishing priorities as to which isolates should be
				collected; and</text>
									</subclause>
                  <subclause id="H6E1A40F82DFA4030B622C4A85001A356">
                    <enum>(VII)</enum>
                    <text>areas for
				government, nongovernment, and international cooperation to strengthen
				implementation of the Public Health Action Plan to Combat Antimicrobial
				Resistance.</text>
									</subclause>
                </clause>
              </subparagraph>
              <subparagraph id="HC882CFE40BEE4154A99ADC92F2A81E9D">
                <enum>(D)</enum>
                <header>Availability of
				information</header>
                <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Antimicrobial Resistance Office" entity-parent-id="7500" proposed="true">Antimicrobial Resistance Office</cato:entity-ref> shall ensure that
				all information shall be made available to the public on the website described
				in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319E/ss:a/p:4/sp:A" proposed="true">subparagraph (A)</cato:entity-ref> consistent with <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Strategies to Address Antimicrobial Resistance Act/s:9" proposed="true">section 9 of the Strategies to Address
				Antimicrobial Resistance
				Act</cato:entity-ref>.</text>
							</subparagraph>
            </paragraph>
            <after-quoted-block>;</after-quoted-block>
          </quoted-block>
				</subparagraph>
      </paragraph>
      <paragraph id="HD4EEFA3C50E7484789D7AE0B63B0A0A9">
        <enum>(2)</enum>
        <text>by amending
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319E/ss:b" proposed="true">subsection (b)</cato:entity-ref> to read as follows:</text>
				<quoted-block id="H502786A87FD84AF489F3AD080FAC1FA4" style="OLC">
					<subsection id="HD7D40B0E51CB49CF9FE5C970B2A0629E">
            <enum>(b)</enum>
            <header>Antimicrobial
				resistance strategic research plan</header>
            <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, acting through
				the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7529">Director of the National Institutes of Health</cato:entity-ref>, working in consultation with
				the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7523">Director of the Centers for Disease Control and Prevention</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Office of the Assistant Secretary for Preparedness and Response" entity-parent-id="7500">Assistant
				Secretary for Preparedness and Response</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Biomedical Advanced Research and Development Authority" entity-parent-id="7500">Director of the Biomedical
				Advanced Research and Development Authority</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Antimicrobial Resistance Office" entity-parent-id="7500" proposed="true">Director of the Antimicrobial
				Resistance Office</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Public Health Antimicrobial Advisory Board" entity-parent-id="7500" proposed="true">Public Health Antimicrobial Advisory Board</cato:entity-ref>, and other
				non-government experts, including representatives from professional societies
				and the pharmaceutical, vaccine, and medical device industries, and other
				Federal agencies shall develop a blue-ribbon antimicrobial resistance strategic
				research plan that strengthens existing epidemiological, interventional,
				clinical, behavioral, translational, and basic research efforts to advance the
				understanding of—</text>
						<paragraph id="H27E3A70CC3654E6888977FCD9F7D0193">
              <enum>(1)</enum>
              <text>the development,
				implementation, and efficacy of interventions to prevent and control the
				emergence and transmission of antimicrobial resistance;</text>
						</paragraph>
            <paragraph id="HDEDD84D2A16845008419E91F42FCD22E">
              <enum>(2)</enum>
              <text>how best to
				optimize antimicrobial effectiveness while limiting the emergence of
				resistance, including addressing issues related to duration of therapy,
				effectiveness of therapy in self-resolving diseases, and determining
				populations most likely to benefit from antimicrobial drugs;</text>
						</paragraph>
            <paragraph id="H4C6A7348372748838203AFD1CAE88568">
              <enum>(3)</enum>
              <text>the extent to
				which specific uses of antimicrobial products in humans, animals, plants, and
				other uses accelerates development and transmission of antimicrobial
				resistance;</text>
						</paragraph>
            <paragraph id="HD50C70F339A44A2CAE1CCC5BE0F65D25">
              <enum>(4)</enum>
              <text>the natural
				histories of infectious diseases (including defining the disease, diagnosis,
				severity, and the time course of illness);</text>
						</paragraph>
            <paragraph id="H8430DE64D2BD4B82A5EE0FEB6EBE43C5">
              <enum>(5)</enum>
              <text>the development of
				new therapeutics, including antimicrobial drugs, biologics, and devices against
				resistant pathogens, and in particular diseases for which few or no
				therapeutics are in development;</text>
						</paragraph>
            <paragraph id="H85762FBB7B924A8B9F0CAD754F2CFC85">
              <enum>(6)</enum>
              <text>the development
				and testing of medical diagnostics to identify patients with infectious disease
				and identify the exact cause of infectious diseases syndromes, particularly
				with respect to the detection of pathogens resistant to antimicrobial
				drugs;</text>
						</paragraph>
            <paragraph id="H123481648AFD4382BF090C402025B77B">
              <enum>(7)</enum>
              <text>the epidemiology,
				pathogenesis, mechanisms, and genetics of antimicrobial resistance; and</text>
						</paragraph>
            <paragraph id="H61AE8E7176CB4523A47BF6327BE97920">
              <enum>(8)</enum>
              <text>the sequencing of
				the genomes, or other DNA analysis, or other comparative analysis of priority
				pathogens (as determined by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Public Health Antimicrobial Advisory Board" entity-parent-id="7500" proposed="true">Public Health Antimicrobial Advisory Board</cato:entity-ref>), in
				collaboration with the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="9700">Department of Defense</cato:entity-ref> and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Joint Genome Institute" entity-parent-id="8900">Joint Genome Institute of
				the Department of
				Energy</cato:entity-ref>.</text>
						</paragraph>
          </subsection>
          <after-quoted-block>;</after-quoted-block>
        </quoted-block>
			</paragraph>
      <paragraph id="HE6D0F60523844F77A167B173B9F2F1D5">
        <enum>(3)</enum>
        <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319E/ss:c">subsection
			 (c)</cato:entity-ref>—</text>
				<subparagraph id="H1411E0807F364FDD99E7BFBA15824832">
          <enum>(A)</enum>
          <text>by inserting
			 <quote>acting through the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Antimicrobial Resistance Office" entity-parent-id="7500" proposed="true">Director of the Antimicrobial Resistance
			 Office</cato:entity-ref>,</quote> after <quote>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>,</quote>; and</text>
				</subparagraph>
        <subparagraph id="HCBCA866710BD4369BD3E1C3DC03790C1">
          <enum>(B)</enum>
          <text>by striking
			 <quote>members of the task force described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319E/ss:a">subsection (a)</cato:entity-ref>,</quote>;</text>
				</subparagraph>
      </paragraph>
      <paragraph id="HF6FEF0E1E2374B55A96B7F23BC481873">
        <enum>(4)</enum>
        <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319E/ss:d/p:1">subsection
			 (d)(1)</cato:entity-ref>, by inserting <quote>, through the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Antimicrobial Resistance Office" entity-parent-id="7500" proposed="true">Antimicrobial Resistance
			 Office</cato:entity-ref>,</quote> after <quote>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>
          </quote>;</text>
			</paragraph>
      <paragraph id="HE4010A1C5A274B60AF89A449D43D184B">
        <enum>(5)</enum>
        <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319E/ss:e">subsection
			 (e)</cato:entity-ref>—</text>
				<subparagraph id="H52819BE685964611A44D6B5E151F4491">
          <enum>(A)</enum>
          <text>by amending the
			 subsection heading to read as follows: <quote>
              <header-in-text level="subsection" style="OLC">Improving Uptake and Measurement of
			 Antimicrobial Stewardship</header-in-text>
            </quote>;</text>
				</subparagraph>
        <subparagraph id="H0E8A04F5118247A7ADC56933D31A0AC3">
          <enum>(B)</enum>
          <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319E/ss:e/p:1">paragraph
			 (1)</cato:entity-ref>—</text>
					<clause id="HC02F542DB3ED4622BF76E390450741FE">
            <enum>(i)</enum>
            <text>by
			 inserting <quote>, acting through the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Antimicrobial Resistance Office" entity-parent-id="7500" proposed="true">Director of the Antimicrobial Resistance
			 Office</cato:entity-ref>,</quote> after <quote>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>
              </quote>; and</text>
					</clause>
          <clause id="HE0F1C257D60B4CD19B754E649C7D7928">
            <enum>(ii)</enum>
            <text>by
			 striking <quote>judicious use of antimicrobial drugs or control the spread of
			 antimicrobial-resistant pathogens</quote> and inserting <quote>the uptake and
			 measurement of antimicrobial stewardship programs in the Nation’s health care
			 facilities</quote>;</text>
					</clause>
        </subparagraph>
        <subparagraph id="HFEE2A44AA8FB49168F473B74A88AE938">
          <enum>(C)</enum>
          <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319E/ss:e/p:2">paragraph (2)</cato:entity-ref>,
			 by striking <quote>laboratory</quote>;</text>
				</subparagraph>
        <subparagraph id="H3008138509504222812B3167B654B1DF">
          <enum>(D)</enum>
          <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319E/ss:e/p:3">paragraph (3)</cato:entity-ref>,
			 by inserting <quote>, acting through the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Antimicrobial Resistance Office" entity-parent-id="7500" proposed="true">Antimicrobial Resistance
			 Office</cato:entity-ref>,</quote> after <quote>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>
            </quote>; and</text>
				</subparagraph>
        <subparagraph id="HA2BF8A5A441D4651925FD8B9F6048695">
          <enum>(E)</enum>
          <text>by adding at the
			 end the following new paragraphs:</text>
					<quoted-block id="H3F0F88C0950B4A4180E473BE6C2808E4" style="OLC">
						<paragraph id="H3F093F8E7B114B4C80E84E2999EF2F60">
              <enum>(4)</enum>
              <header>Definition of
				antimicrobial stewardship</header>
              <text>For purposes of this subsection and
				Act, <term>antimicrobial stewardship</term> means coordinated interventions
				designed to improve and measure the appropriate use of antimicrobial agents,
				including promoting the use of antimicrobials only when clinically indicated,
				and, when antimicrobials are indicated, promoting the selection of the optimal
				antimicrobial drug regimen including dosing, duration of therapy, and route of
				administration.</text>
						</paragraph>
            <paragraph id="H3A5B4BCD9C634367AE14A2FC60340A03">
              <enum>(5)</enum>
              <header>Preference in
				making awards</header>
              <text>In making awards under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319E/ss:e/p:1">paragraph (1)</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>
				shall give preference to eligible entities that will use grant funds to
				establish demonstration projects that lead to the development of quality
				measures for health care providers prescribing antimicrobial
				drugs.</text>
						</paragraph>
            <after-quoted-block>;
				</after-quoted-block>
          </quoted-block>
				</subparagraph>
      </paragraph>
      <paragraph id="H57FA97A937294FF198141454678DB0CC">
        <enum>(6)</enum>
        <text>by redesignating
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319E/ss:f, g">subsections (f) and (g)</cato:entity-ref> as <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319E/ss:i, j" proposed="true">subsections (i) and (j)</cato:entity-ref>, respectively; and</text>
			</paragraph>
      <paragraph id="HCFB5AE1BBB284EAAA2FB5EE61001F99D">
        <enum>(7)</enum>
        <text>by inserting after
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319E/ss:e">subsection (e)</cato:entity-ref> the following new subsections:</text>
				<quoted-block id="H23C3FB41360148DCA370145E9A092674" style="OLC">
					<subsection commented="no" id="H9B2081F9150344E5B65C2D5D47B98A9D">
            <enum>(f)</enum>
            <header>Appropriate
				antimicrobial use</header>
            <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, acting through the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7523">Director of
				the Centers for Disease Control and Prevention</cato:entity-ref>, shall take such additional
				actions as follows:</text>
						<paragraph commented="no" id="H7A82B8E916DC4809912629C9085A1938">
              <enum>(1)</enum>
              <text>To pilot and test
				health care quality measures to help providers, facilities, and health systems
				measure and benchmark appropriate antimicrobial use. As appropriate, the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7523">Director</cato:entity-ref> shall work with standard setting organizations (such as the National
				Quality Forum, the Joint Commission, and the National Committee for Quality
				Assurance) to determine if any such measure is suitable for national quality
				reporting efforts.</text>
						</paragraph>
            <paragraph commented="no" id="H104BEC67DA7946C086DCB8CBD94F7355">
              <enum>(2)</enum>
              <text>To develop methods
				to help providers, facilities, and health systems measure and improve
				appropriate antimicrobial use, including methods and tools to assess the change
				in antimicrobial use, the impact on antibiotic resistance and adverse effects
				(such as Clostridium difficile infections), and the economic impact and cost
				savings of antimicrobial stewardship programs.</text>
						</paragraph>
          </subsection>
          <subsection id="HC8E2B7F1B89A46EF8D6AB3F7BADEB518">
            <enum>(g)</enum>
            <header>Collection of
				human antimicrobial consumption and resistance trend data</header>
						<paragraph id="HA4EFB088F7EB4A32ACA657BE41213268">
              <enum>(1)</enum>
              <header>Antimicrobial
				Use Data</header>
              <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7523">Director of the Centers for Disease Control and
				Prevention</cato:entity-ref> shall work with private vendors, health care organizations, pharmacy
				benefit managers, and other entities to obtain reliable and comparable human
				antimicrobial drug consumption data (including volume antimicrobial
				distribution data and antimicrobial use, including prescription data) by State
				or metropolitan area.</text>
						</paragraph>
            <paragraph id="HAC5CD45C62824DC68FB921D0FE03AF47">
              <enum>(2)</enum>
              <header>Antimicrobial
				Resistance Trend Data</header>
              <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7523">Director of the Centers for Disease
				Control and Prevention</cato:entity-ref> shall intensify and expand their efforts to collect
				antimicrobial resistance data including through the establishment of an
				Antimicrobial Resistance Surveillance and Laboratory Network, established in
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Strategies to Address Antimicrobial Resistance Act/s:4" proposed="true">section 4 of the Strategies to Address Antimicrobial Resistance Act</cato:entity-ref>, and
				development of a fully automated antimicrobial resistance and use module within
				the National Healthcare Safety Network. The Director shall seek to collect data
				from electronic medication administration reports (eMAR) and laboratory systems
				to produce regular reports on antimicrobial resistance patterns and
				antimicrobial use.</text>
						</paragraph>
            <paragraph id="H445CFBF201A2488183EA4751C0ECFD53">
              <enum>(3)</enum>
              <header>Meaningful Use
				Reporting</header>
              <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Office of the National Coordinator for Health Information Technology" entity-parent-id="7500">Office of the National Coordinator for Health
				Information Technology</cato:entity-ref> shall work with the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7523">Director of the Centers for Disease
				Control and Prevention</cato:entity-ref> to determine how best antimicrobial use, susceptibility,
				and resistance data can be incorporated into meaningful use reporting.</text>
						</paragraph>
            <paragraph id="H72FEF540ECB44E279BD1EC1960A63B38">
              <enum>(4)</enum>
              <header>Report</header>
              <text>Not
				later than 2 years after the date of the enactment of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Strategies to Address Antimicrobial Resistance Act" proposed="true">Strategies to Address
				Antimicrobial Resistance Act</cato:entity-ref>, and every two years thereafter, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7523">Director of
				the Centers for Disease Control and Prevention</cato:entity-ref> shall submit to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="committee" entity-id="HIF00">Committee on
				Energy and Commerce of the House of Representatives</cato:entity-ref> and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="committee" entity-id="SSHR00">Committee on
				Health, Education, Labor and Pensions of the Senate</cato:entity-ref> and make available on the
				agency’s website a report summarizing key trends and major issues related to
				antimicrobial resistance and use in the United States. Each such report shall
				include the most relevant and up-to-date data available from the infectious
				diseases and surveillance programs of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7523">Centers for Disease Control and
				Prevention</cato:entity-ref>. Each such report shall—</text>
							<subparagraph id="HC0CA37FAE69944569FC240DC6F9CAB88">
                <enum>(A)</enum>
                <text>outline major
				issues and threats in antimicrobial resistance facing the United States;</text>
							</subparagraph>
              <subparagraph id="H0671E025C0434AFBAE2BC2DC97AC7B35">
                <enum>(B)</enum>
                <text>provide data on
				the incidence, prevalence, morbidity, mortality, and general societal burden,
				including economic, of antimicrobial resistant pathogens;</text>
							</subparagraph>
              <subparagraph id="H80CA4C72B8394F05BE1B16CF22A90A08">
                <enum>(C)</enum>
                <text>provide updates on
				resistance patterns and antimicrobials use data and potential impacts on human
				health and patient safety;</text>
							</subparagraph>
              <subparagraph id="H9C7EB40AF71D4B76A77BA171E4C67714">
                <enum>(D)</enum>
                <text>articulate
				activities of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7523">Centers for Disease Control and Prevention</cato:entity-ref> targeted toward
				measuring and preventing the spread of drug resistant pathogens;</text>
							</subparagraph>
              <subparagraph id="H1F80BB61EA1A4A6C865F16D3D06F19B8">
                <enum>(E)</enum>
                <text>describe any
				international developments that may impact antimicrobial resistance in the
				United States; and</text>
							</subparagraph>
              <subparagraph id="H4AA9A596552E48519D233BBF3C08CB6B">
                <enum>(F)</enum>
                <text>identify the major
				gaps that the Nation faces in the areas of antimicrobial resistance
				surveillance, prevention, use, and antimicrobial stewardship.</text>
							</subparagraph>
            </paragraph>
          </subsection>
          <subsection id="HB3DB51D8F608411297FD4BF0D1E26C69">
            <enum>(h)</enum>
            <header>Ensure access to
				antimicrobial resistance data and research</header>
            <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Antimicrobial Resistance Task Force" entity-parent-id="7500" proposed="true">Director of the Antimicrobial
				Resistance Office</cato:entity-ref> shall work with the Federal agencies represented on the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Antimicrobial Resistance Task Force" entity-parent-id="7500" proposed="true">Antimicrobial Resistance Task Force</cato:entity-ref> to identify relevant data and formats, and
				mechanisms for communicating such data to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Antimicrobial Resistance Office" entity-parent-id="7500" proposed="true">Antimicrobial Resistance Office</cato:entity-ref>
				and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Antimicrobial Resistance Task Force" entity-parent-id="7500" proposed="true">Antimicrobial Resistance Task Force</cato:entity-ref> and, in a manner consistent with
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Strategies to Address Antimicrobial Resistance Act/s:9" proposed="true">section 9 of the Strategies to Address Antimicrobial Resistance Act</cato:entity-ref>, with the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Public Health Antimicrobial Advisory Board" entity-parent-id="7500" proposed="true">Public Health Antimicrobial Advisory Board</cato:entity-ref> and the public, including relevant
				data obtained by the agencies through contracts with other organizations,
				including—</text>
						<paragraph id="HF9691CC13CF04D6DA69454B7F994DBB7">
              <enum>(1)</enum>
              <text>use and clinical
				outcomes data on patients receiving antimicrobial drugs for the treatment,
				prevention, or diagnosis of infection or infectious diseases;</text>
						</paragraph>
            <paragraph id="H063064BACDF743E8B22F93797B6A2F9C">
              <enum>(2)</enum>
              <text>surveillance data
				regarding emerging antimicrobial drug resistance and existing resistance
				patterns;</text>
						</paragraph>
            <paragraph id="H538E0CB7D10743A282156E1685CB470E">
              <enum>(3)</enum>
              <text>susceptibility
				data related to antimicrobial drug use;</text>
						</paragraph>
            <paragraph id="H0279BCE6F4B040AE999B7F52100F9159">
              <enum>(4)</enum>
              <text>data related to
				the amount of antimicrobial products used in humans, animals, plants, and the
				environment;</text>
						</paragraph>
            <paragraph id="H8FA4BC5C6C05486D9FF29F39C6AA8B59">
              <enum>(5)</enum>
              <text>data from
				federally funded research intended to support antimicrobial drug, vaccine, and
				related diagnostics development;</text>
						</paragraph>
            <paragraph id="H5339E1C60AFB4ECEAA31064CD6690074">
              <enum>(6)</enum>
              <text>data demonstrating
				the impact of research, surveillance, and prevention and control initiatives in
				understanding and controlling antimicrobial resistance; and</text>
						</paragraph>
            <paragraph id="HAE7EA68DDBEF4235AEFD8FBD066371D0">
              <enum>(7)</enum>
              <text>data regarding
				implementation and evaluation of interventions to improve antimicrobial drug
				prescribing
				practices.</text>
						</paragraph>
          </subsection>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
			</paragraph>
    </section>
    <section id="HC7D00DF9F421463E83E8E71DB46CBBCA">
      <enum>4.</enum>
      <header>Antimicrobial
			 resistance surveillance and laboratory network</header>
			<subsection id="H7C9031D5F87D4BF9940AE3A12BD8F852">
        <enum>(a)</enum>
        <header>In
			 general</header>
        <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary of Health and Human Services</cato:entity-ref>, acting
			 through the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7523">Director of the Centers for Disease Control</cato:entity-ref>, shall establish at
			 least 10 Antimicrobial Resistance Surveillance and Laboratory Network sites,
			 building upon the intramural and extramural programs and laboratories of the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7523">Centers for Disease Control and Prevention</cato:entity-ref>, to intensify, strengthen, and
			 expand the national capacity to—</text>
				<paragraph id="H14358735982B4E15B8630D58B02371DD">
          <enum>(1)</enum>
          <text>monitor the
			 emergence and changes in the patterns of antimicrobial resistant
			 pathogens;</text>
				</paragraph>
        <paragraph id="H5498A3A9CC2F4F7BB7BF30827BED40B8">
          <enum>(2)</enum>
          <text>describe, confirm,
			 and as necessary facilitate a response to local or regional outbreaks of
			 resistant pathogens;</text>
				</paragraph>
        <paragraph id="H1D97350F854B46DE9366DE2E12962F6A">
          <enum>(3)</enum>
          <text>assess and
			 describe antimicrobial resistance patterns to inform public health and improve
			 prevention practices;</text>
				</paragraph>
        <paragraph id="H265D852C9FBB405F9811D8294A9A6274">
          <enum>(4)</enum>
          <text>obtain isolates of
			 pathogens, and in particular, pathogens that show new or atypical patterns of
			 resistance adversely affecting public health;</text>
				</paragraph>
        <paragraph id="HAA6EFB3EEBAD47C09EDC261EF7C076BD">
          <enum>(5)</enum>
          <text>study the
			 epidemiology of infections from such pathogens;</text>
				</paragraph>
        <paragraph id="HFE70454581934FBFB4C00C8DA992C7AE">
          <enum>(6)</enum>
          <text>evaluate commonly
			 used antimicrobial susceptibility testing methods to improve the accuracy of
			 resistance testing and reporting; and</text>
				</paragraph>
        <paragraph id="H87E2498D614B4E33A8760174AA0EA0BB">
          <enum>(7)</enum>
          <text>as necessary,
			 develop novel diagnostic tests capable of detecting new or emerging resistance
			 in pathogens.</text>
				</paragraph>
      </subsection>
      <subsection id="H0C1D35ED0F274A1D9DCB0EA73D5C51A4">
        <enum>(b)</enum>
        <header>Geographic
			 distribution</header>
        <text>The sites established under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Strategies to Address Antimicrobial Resistance Act/s:4/ss:a" proposed="true">subsection (a)</cato:entity-ref> shall be
			 geographically distributed across the United States.</text>
			</subsection>
      <subsection id="HA95BBF5D18364A509610FBDFE0CB4F3B">
        <enum>(c)</enum>
        <header>Nonduplication
			 of current national capacity</header>
        <text>The sites established under
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Strategies to Address Antimicrobial Resistance Act/s:4/ss:a" proposed="true">subsection (a)</cato:entity-ref> may be based in academic centers, health departments, and
			 existing surveillance and laboratory sites.</text>
			</subsection>
    </section>
    <section id="HD9DAC9BDE98C4BA381AE702F06936B26">
      <enum>5.</enum>
      <header>Clinical trials
			 network on antibacterial resistance</header>
			<subsection id="H896C8C73DCBB44F6BD26F2584569C769">
        <enum>(a)</enum>
        <header>In
			 General</header>
        <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, acting through the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="National Institute of Allergy and Infectious Diseases" entity-parent-id="7529">Director of the
			 National Institute of Allergy and Infectious Diseases</cato:entity-ref>, shall establish a
			 Clinical Trials Network on Antibacterial Resistance to enhance, strengthen, and
			 expand research on clinical science, antibacterial and diagnostic development,
			 and optimal usage strategies, and shall, at a minimum—</text>
				<paragraph id="HCBEC3F74ED1E4501846B8FF375B99A0E">
          <enum>(1)</enum>
          <text>facilitate
			 research to better understand resistance mechanisms and how to prevent,
			 control, and treat resistant organisms;</text>
				</paragraph>
        <paragraph id="HC36DAF99B1C048E19458F0F623659C04">
          <enum>(2)</enum>
          <text>advance clinical
			 trial efforts to develop antimicrobial therapies, vaccines and diagnostics, and
			 evaluate and optimize their usage;</text>
				</paragraph>
        <paragraph id="H30FFA122FF414A15AA9C45678B0BDB8A">
          <enum>(3)</enum>
          <text>conduct clinical
			 research to develop natural histories of resistant infectious diseases;</text>
				</paragraph>
        <paragraph id="H025DDFC33FD840DBB26E7116642C313F">
          <enum>(4)</enum>
          <text>examine patient
			 outcomes with currently available antimicrobial therapy and validate and
			 improve upon biomarkers and other surrogate end­points; and</text>
				</paragraph>
        <paragraph id="H40C65419752E45F585BE30C85C6A0480">
          <enum>(5)</enum>
          <text>study shorter
			 treatment duration and early cessation of antimicrobial therapy for treatment
			 efficacy and effect on development of resistance.</text>
				</paragraph>
      </subsection>
      <subsection id="H00740224290D4D82A694A0206C271928">
        <enum>(b)</enum>
        <header>Leadership Group
			 for a Clinical Research Network on Antibacterial Resistance</header>
        <text>The
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, acting through the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="National Institute of Allergy and Infectious Diseases" entity-parent-id="7529">Director of the National Institute of Allergy and
			 Infectious Diseases</cato:entity-ref>, shall establish a Leadership Group for the Clinical
			 Research Network on Antibacterial Resistance described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Strategies to Address Antimicrobial Resistance Act/s:5/ss:a" proposed="true">subsection (a)</cato:entity-ref> to
			 develop and implement a comprehensive clinical research agenda to address
			 antibacterial resistance that takes into consideration the recommendations
			 contained in the Strategic Research Plan on Antimicrobial Resistance developed
			 in accordance with <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319E">section 319E of the Public Health Service Act</cato:entity-ref>. The
			 Leadership Group shall provide support for the following components—</text>
				<paragraph id="HBBD58F00923040B5B8D8EC6D2F2BF5F9">
          <enum>(1)</enum>
          <text>scientific
			 leadership and operations;</text>
				</paragraph>
        <paragraph id="H784579C7FF174A379F29BD792F6F85A1">
          <enum>(2)</enum>
          <text>network
			 laboratories; and</text>
				</paragraph>
        <paragraph id="HD22BF395A7A14F88B605DD17EAD95685">
          <enum>(3)</enum>
          <text>statistical and
			 data management.</text>
				</paragraph>
      </subsection>
      <subsection id="HFEAA14DA74F747F8BCF3EE94F2306DDE">
        <enum>(c)</enum>
        <header>Appropriations</header>
        <text>
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="auth-auth-approp">There
			 are authorized to be appropriated <cato:property name="funds-source">from the existing budget of the <cato:entity-ref entity-type="federal-body" value="National Institute of Allergy and Infectious Diseases" entity-parent-id="7529">National
			 Institute of Allergy and Infectious Diseases</cato:entity-ref>
            </cato:property>, <cato:funds-and-year amount="100000000" year="2014, 2015, 2016, 2017, 2018, 2019, 2020">$100,000,000 annually for each of
			 fiscal years 2014 through 2020</cato:funds-and-year> <cato:property name="purpose">to carry out <cato:entity-ref entity-type="act" value="Strategies to Address Antimicrobial Resistance Act/s:5" proposed="true">this section</cato:entity-ref>
            </cato:property>.</cato:entity>
        </text>
			</subsection>
    </section>
    <section id="H7FF4236440E94A85A235205F5A849D8C">
      <enum>6.</enum>
      <header>Regional
			 prevention collaboratives</header>
      <text display-inline="no-display-inline">The
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>, acting through the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7523">Director of the Centers for Disease Control and
			 Prevention</cato:entity-ref>, shall work with State health departments to support regional
			 prevention collaboratives designed to interrupt and prevent the transmission of
			 significant antibiotic resistant pathogens being transmitted across health care
			 settings in a geographic region. Such regional prevention collaboratives shall
			 work to—</text>
			<paragraph id="HC410DA184C384FF6B0084AF4FA3D5AE6">
        <enum>(1)</enum>
        <text>identify
			 significant drug resistant pathogens being transmitted across health care
			 settings locally;</text>
			</paragraph>
      <paragraph id="HC8ABFC292A9E4A67910792F8BB9DD4F4">
        <enum>(2)</enum>
        <text>implement
			 evidence-based interventions to interrupt and prevent the transmission of such
			 pathogens; and</text>
			</paragraph>
      <paragraph id="HC0AB75367D5F4C4CB908FE11F6FD801D">
        <enum>(3)</enum>
        <text>evaluate the
			 impact of such measures on hospital readmissions, transitions of care, rates of
			 health care associated infections, or any other relevant measures that
			 characterize the health or economic impact of the collaboratives.</text>
			</paragraph>
    </section>
    <section commented="no" id="HE34012EB0CF740BEA4FAB1F856B291B9">
      <enum>7.</enum>
      <header>Prevention
			 Epicenters</header>
      <text display-inline="no-display-inline">To provide the
			 regional prevention collaboratives established under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Strategies to Address Antimicrobial Resistance Act/s:6" proposed="true">section 6</cato:entity-ref> with tools,
			 strategies, and evidence-based interventions, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7523">Director of the Centers for
			 Disease Control and Prevention</cato:entity-ref> may intensify and expand academic public health
			 partnerships through the work of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Prevention Epicenters Program" entity-parent-id="7523">Prevention Epicenters Program of the
			 Centers of Disease Control and Prevention</cato:entity-ref>. The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7523">Centers for Disease Control and
			 Prevention</cato:entity-ref> and the epicenters participating in such program shall work with the
			 regional prevention collaboratives to—</text>
			<paragraph commented="no" id="HE8671FA9603D4D8D924A65DEB0DF6781">
        <enum>(1)</enum>
        <text>evaluate new and
			 existing interventions to prevent or limit the emergence of antimicrobial
			 resistance throughout the geographic region of the collaboratives;</text>
			</paragraph>
      <paragraph commented="no" id="H3D7B5C7A74004C4B897229CAAB8ED477">
        <enum>(2)</enum>
        <text>facilitate public
			 health research on the prevention and control of resistant organisms;
			 and</text>
			</paragraph>
      <paragraph commented="no" id="H2059E68D9E7446E4A761198668EE5396">
        <enum>(3)</enum>
        <text>assess the
			 feasibility, cost-effectiveness, and appropriateness of surveillance and
			 prevention programs in differing health care and institutional settings.</text>
			</paragraph>
    </section>
    <section id="HACC72A262F8B4BDBBD8F6740D2E1B0B5">
      <enum>8.</enum>
      <header>Continuation of
			 current programs</header>
      <text display-inline="no-display-inline">
        <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:319E/ss:j">Subsection
			 (j)</cato:entity-ref> of <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
          <cato:entity-ref entity-type="act" value="Public Health Service Act/s:319E">section 319E of the Public Health Service Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/247d-5">
            <cato:entity-ref entity-type="uscode" value="usc/42/247d–5">42 U.S.C. 247d–5</cato:entity-ref>
          </external-xref>)</cato:entity>, as
			 redesignated by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Strategies to Address Antimicrobial Resistance Act/s:3/p:6" proposed="true">section 3(6)</cato:entity-ref>, is amended by inserting <quote>
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="auth-auth-approp">and <cato:funds-and-year amount="indefinite" year="2014, 2015, 2016, 2017, 2018">for each of
			 the fiscal years 2014 through 2018</cato:funds-and-year>
          </cato:entity>
        </quote> after <quote>2006</quote>.</text>
		</section>
    <section id="H5C15B5E98C934559BB3735E940AFE487">
      <enum>9.</enum>
      <header>Protection of
			 confidential and national security information</header>
      <text display-inline="no-display-inline">Except as otherwise required by law, this
			 Act (and the amendments made by this Act) shall not permit public disclosure of
			 trade secrets, confidential commercial information, or material inconsistent
			 with national security that is obtained by any person under this Act (or
			 amendments made by this Act).</text>
		</section>
  </legis-body>
</bill>
</doc>